Literature DB >> 24998163

Influence of MRI-based bone outline definition errors on external radiotherapy dose calculation accuracy in heterogeneous pseudo-CT images of prostate cancer patients.

Juha Korhonen1, Mika Kapanen, Jani Keyriläinen, Tiina Seppälä, Laura Tuomikoski, Mikko Tenhunen.   

Abstract

BACKGROUND: This work evaluates influences of susceptibility-induced bone outline shift and perturbations, and bone segmentation errors on external radiotherapy dose calculation accuracy in magnetic resonance imaging (MRI)-based pseudo-computed tomography (CT) images of the male pelvis.
MATERIAL AND METHODS: T₁/T₂*-weighted fast gradient echo, T₁-weighted spin echo and T₂-weighted fast spin echo images were used in bone detection investigation. Bone edge location and bone diameter in MRI were evaluated by comparing those in the images with actual physical measurements of fresh deer bones positioned in a gelatine phantom. Dose calculation accuracy in pseudo-CT images was investigated for 15 prostate cancer patients. Bone outlines in T₁/T₂*-weighted images were contoured and additional segmentation errors were simulated by expanding and contracting the bone contours with 1 mm spacing. Heterogeneous pseudo-CT images were constructed by adopting a technique transforming the MRI intensity values into Hounsfield units with separate conversion models within and outside of bone segment.
RESULTS: Bone edges and diameter in the phantom were illustrated correctly within a 1 mm-pixel size in MRI. Each 1 mm-sized systematic error in bone segment resulted in roughly 0.4% change to the prostate dose level in the pseudo-CT images. The prostate average (range) dose levels in pseudo-CT images with additional systematic bone segmentation errors of -2 mm, 0 mm and 2 mm were 0.5% (-0.5-1.4%), -0.2% (-1.0-0.7%), and -0.9% (-1.8-0.0%) compared to those in CT images, respectively, in volumetric modulated arc therapy treatment plans calculated by Monte Carlo algorithm.
CONCLUSIONS: Susceptibility-induced bone outline shift and perturbations do not result in substantial uncertainty for MRI-based dose calculation. Dose consistency of 2% can be achieved reliably for the prostate if heterogeneous pseudo-CT images are constructed with ≤± 2 mm systematic error in bone segment.

Entities:  

Mesh:

Year:  2014        PMID: 24998163     DOI: 10.3109/0284186X.2014.929737

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

1.  Magnetic resonance imaging-based pseudo computed tomography using anatomic signature and joint dictionary learning.

Authors:  Yang Lei; Hui-Kuo Shu; Sibo Tian; Jiwoong Jason Jeong; Tian Liu; Hyunsuk Shim; Hui Mao; Tonghe Wang; Ashesh B Jani; Walter J Curran; Xiaofeng Yang
Journal:  J Med Imaging (Bellingham)       Date:  2018-08-24

Review 2.  Emerging role of MRI in radiation therapy.

Authors:  Hersh Chandarana; Hesheng Wang; R H N Tijssen; Indra J Das
Journal:  J Magn Reson Imaging       Date:  2018-09-08       Impact factor: 4.813

3.  Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities.

Authors:  Tiina Seppälä; Harri Visapää; Juhani Collan; Mika Kapanen; Annette Beule; Mauri Kouri; Mikko Tenhunen; Kauko Saarilahti
Journal:  Strahlenther Onkol       Date:  2015-07-14       Impact factor: 3.621

4.  MRI-Based Proton Treatment Planning for Base of Skull Tumors.

Authors:  Ghazal Shafai-Erfani; Yang Lei; Yingzi Liu; Yinan Wang; Tonghe Wang; Jim Zhong; Tian Liu; Mark McDonald; Walter J Curran; Jun Zhou; Hui-Kuo Shu; Xiaofeng Yang
Journal:  Int J Part Ther       Date:  2019-09-30

5.  Estimation and evaluation of pseudo-CT images using linear regression models and texture feature extraction from MRI images in the brain region to design external radiotherapy planning.

Authors:  Niloofar Yousefi Moteghaed; Ahmad Mostaar; Keivan Maghooli; Mohammad Houshyari; Ahmad Ameri
Journal:  Rep Pract Oncol Radiother       Date:  2020-07-11

Review 6.  A review of substitute CT generation for MRI-only radiation therapy.

Authors:  Jens M Edmund; Tufve Nyholm
Journal:  Radiat Oncol       Date:  2017-01-26       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.